Left Menu
Development News Edition

Indian pharma exports may touch $22 bn in FY '20: Pharmexcil

PTI | Hyderabad | Updated: 13-09-2019 15:42 IST | Created: 13-09-2019 15:42 IST
Indian pharma exports may touch $22 bn in FY '20: Pharmexcil

Indian pharma exports may touch $22 bn in FY '20: Pharmexcil Hyderabad, Sep 13 (PTI): Pinning hopes on the recovery of the USA market, a top official of the Pharmaceuticals Export Promotion Council of India (Pharmexcil)on Friday said Indian pharma exports may touch USD 22 billion during the current financial year against USD 19.14 billion in FY '19. Speaking to reporters, director-general of Pharmexcil, a body under the Ministry of Commerce and Industry, Uday Bhasker said some of the policy decisions being taken by the Chinese government may align favourably to Indian pharma exporters.

In July 2019, Indian exports recorded 21.7 per cent growth to 1.72 billion (total exports from April to July this year was at USD 6.17 billion), he said. The cumulative growth of Indian exports for the period April-July was 13 per cent.

As of June 2019, Indias generic pharmaceutical exports have grown almost 2.7 to 2.8 times faster than the market (global generic market), he said. "Hence, we expect the exports to touch USD 22 billion in the fiscal 2019-20," Bhaskar said.

"The prices (in USA market) are now stabilised. Even when there was price erosion, our export volumes were growing. That is why the US market has revived," he said. Despite price erosion and cartelisation in the USA market, the market there started recovering with 13.72 per cent growth in FY '19 against negative growth of eight per cent in FY '18, Bhaskar said.

Exports to North America, Africa and European Union contribute nearly 66 per cent of the total Indian pharma exports comprising bulk drugs, finished dosage formulations, Ayush and herbals and surgical, statistics supplied by the Pharmexcil said. On exports to China and Japan markets, the official said the Japan market was basically not favourable for generic drugs and also doctors in that country were also not willing to promote generic versions.

The registration of drugs in China takes lot of time for Indian companies. There was some policy change last year which was perceived as an opportunity for Indian exporters, he said. According to him, India currently imports APIs (Active Pharmaceutical Ingredient) and other chemicals worth USD 2.5 billion from China while drug exports to the country was at USD 230 million.

Pharmexcil would be organising a two-day 'International Regulators Meet' here on September 19 and 20. About 40 delegates, including some drug regulators, from 25 countries are expected to participate in the meet, Bhaskar said..


TRENDING

OPINION / BLOG / INTERVIEW

Post-COVID-19 Nigeria needs a robust Health Management Information System to handle high disease burden

Nigeria is among a few countries that conceptualised a health management information system HMIS in the early 90s but implementation has been a challenge till date. Besides COVID-19, the country has a huge burden of communicable and non-com...

Morocco COVID-19 response: A fragile health system and the deteriorating situation

Learning from its European neighbors, Morocco imposed drastic measures from the initial stages of the COVID-19 outbreak to try to contain its spread. The strategy worked for a few months but the cases have surged after mid-June. In this sit...

COVID-19: Argentina’s health system inefficiencies exaggerate flaws of health information system

You can recover from a drop in the GDP, but you cant recover from death, was the straightforward mindset of Argentinas President Alberto Fernndez and defined the countrys response to COVID-19. The South American nation imposed a strict...

Videos

Latest News

IKEA to adopt omni-channel approach for expansion in India

The COVID-19 pandemic has slowed down Swedish furniture retailer IKEAs expansion plans in India but the company is adjusting to the new reality while continuing to bet on the country as one of its very important markets, according to compan...

Congress MLA Dinesh Gundu Rao tests positive for COVID-19

Karnataka Congress leader and MLA Dinesh Gundu Rao on Sunday said he has tested positive for COVID-19. I have tested Corona positive today.Therefore will be quarantining myself for 10 days. I request all my primary contacts to get themselve...

Travellers from Dubai, UK contributed maximum COVID-19 importations into India: IIT study

Travellers from Dubai and the UK were primary sources of COVID-19 importations into India, according to an analytical study done by Indian Institute of Technology IIT, Mandi. According to the research, which has been published in the Journa...

Proud Boys Portland rally largely peaceful but clashes downtown

Hundreds of supporters of the right-wing Proud Boys group rallied in Portland, Oregon on Saturday in a largely peaceful event but police and left-wing protesters later clashed in the citys downtown. The Proud Boys rally in a north Portland ...

Give Feedback